Showing results (2041-2050 of 2,492) with videos related to
Sort By:
Pageof 250
Nature Nanotechnology|December 4, 2023
Ultraviolet interlayer excitons in bilayer WSe<sub>2</sub>Kai-Qiang Lin, Paulo E Faria Junior, Ruven Hübner, et al.Journal of the International Neuropsychological Society : JINS|July 21, 2023
Computerized adaptive test strategies for the matrix reasoning subtest of the Wechsler Adult Intelligence Scale, 4th Edition (WAIS-IV)Steven P Reise, Emily Wong, Jared Block, et al.Molecular Medicine (Cambridge, Mass.)|September 9, 2015
The HIV Protease Inhibitor Saquinavir Inhibits HMGB1-Driven Inflammation by Targeting the Interaction of Cathepsin V with TLR4/MyD88John P Pribis, Yousef Al-Abed, Huan Yang, et al.Frontiers in Oncology|December 27, 2024
<i>GSTM1</i> null genotype underpins recurrence of <i>NF2</i> meningiomasAnthony C Johnson, Erdyni N Tsitsikov, Khanh P Phan, et al.Cancer Discovery|July 27, 2019
Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell HistiocytosisFlorian Halbritter, Matthias Farlik, Raphaela Schwentner, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 2, 2019
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLCTodd M Bauer, Benjamin Besse, Alex Martinez-Marti, et al.Sports Medicine (Auckland, N.Z.)|February 23, 2026
Symptom Resolution Characteristics: Initial Symptom Trajectories of Collegiate Students with and without Persisting Symptoms After ConcussionKumiko Hashida, Eric J Shumski, Donna K Broshek, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)Tara C Mitchell, Omid Hamid, David C Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced CancerDavid Hong, Jeffrey Infante, Filip Janku, et al.Pageof 250